Adaptive Biotechnologies
ADPT
ADPT
196 hedge funds and large institutions have $4.89B invested in Adaptive Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
29% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 49
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
2.76% more ownership
Funds ownership: 76.87% → 79.63% (+2.8%)
Holders
196
Holding in Top 10
5
Calls
$14.1M
Puts
$7.06M
Top Buyers
| 1 | +$59.3M | |
| 2 | +$56.6M | |
| 3 | +$48.7M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$38.8M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$36.3M |
Top Sellers
| 1 | -$133M | |
| 2 | -$84.1M | |
| 3 | -$28.1M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$13.6M |